View Post

Lyme Disease Testing May Depend on Autoantibody Biomarkers

In COVID-19, Latest News by Precision Vaccinations

Researchers at Massachusetts-based Tufts University School of Medicine recently announced they identified a testing mechanism that detects a type of antibody, infected individuals produce, against a substance the Lyme bacteria acquires from the host to grow. 
These researchers stated on March 15, 2022, they believe tests to detect auto-antibodies, which are antibodies that mistakenly target and react with a person's tissues or organs, could empower clinicians with a way to diagnose Lyme disease sooner.